NanoViricides
NNVC
48 hedge funds and large institutions have $7.3M invested in NanoViricides in 2015 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 17 closing their positions.
933% more call options, than puts
Call options by funds: $31K | Put options by funds: $3K
0.13% less ownership
Funds ownership: 0.48% → 0.35% (-0.13%)
8% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 13
17% less funds holding
Funds holding: 58 → 48 (-10)
44% less capital invested
Capital invested by funds: $13.1M → $7.3M (-$5.78M)
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Top Buyers
Top Sellers
NNVC Hedge Fund Activity: Q2 2015 in Review
48 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2015, worth a combined $7.3M — down 44% from $13.1M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of NNVC and 8 opened new positions — a net loss of 9 holders — while 13 trimmed existing stakes and 12 added.
The largest buyer was Susquehanna International Group, adding an estimated $423K. The largest seller was BlackRock Fund Advisors, cutting an estimated $2.05M.
- 48 institutional investors held NanoViricides (NNVC) as of Q2 2015, down from 58 in Q1 2015.
- Funds reported $7.3M of NanoViricides stock for Q2 2015, down 44% quarter-over-quarter.
- 8 funds opened new NanoViricides positions in Q2 2015 and 17 closed out, a net change of -9 holders.
- The largest NanoViricides buyer in Q2 2015 was Susquehanna International Group, an estimated $423K added.
- The largest NanoViricides seller in Q2 2015 was BlackRock Fund Advisors, an estimated $2.05M sold.
Based on aggregated 13F filings for Q2 2015.